Perkins Coie is pleased to announce that Mark R. Wicker has joined the firm’s Technology Transactions & Privacy practice as a partner in San Diego. Previously, Mark was a partner at Morrison Foerster.

“Mark joins Perkins Coie as established and respected counsel who shares clients with several of our life sciences partners,” said Thomas Bell, co-chair of Perkins Coie’s Technology Transactions & Privacy practice. “While much of his focus is on life sciences technologies, he has extensive experience creating effective business solutions for companies that complement our growing tech-focused emerging companies practice. With such strong standing in cross over practices, we are delighted to welcome Mark to the firm.”

Mark advises clients in all aspects of acquiring, developing, commercializing and licensing new technologies and products. He has significant experience structuring strategic alliances, collaborations, joint ventures, licenses, and research development, manufacturing and distribution relationships, often using novel approaches and pioneering methods that further his clients’ business objectives. His clients range from startups to well-established firms in the life sciences, technology, wireless, social media, clean technology, chemical and material sciences industries. During his many years of practice, Mark has built a reputation for developing sophisticated business models and formulating business-centric legal solutions to the complex challenges biotechnology and life sciences companies face as they bring novel therapeutics and diagnostics to market. Mark earned his J.D. from Columbia University School of Law and received his A.B. from Stanford University.

“Mark is a solid licensing and commercial lawyer who consistently provides strategic counsel on high profile matters to life sciences and technology clients in Southern California and throughout the world,” said Matthew Bernstein, Office Managing Partner of Perkins Coie’s San Diego office. “Along with our robust California patent practice, Mark’s work expands and enhances our established reputation as a go-to life sciences firm.”


Related Posts:

Leave a Reply